Loading...
Neurocrine Biosciences, Inc.
NBIX•NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$125.34
$0.73(0.59%)
Neurocrine Biosciences, Inc. (NBIX) Financial Performance & Statements
Review Neurocrine Biosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
24.81%
↑ 24.81%
Operating Income Growth
127.38%
↑ 127.38%
Net Income Growth
36.68%
↑ 36.68%
Operating Cash Flow Growth
52.71%
↑ 52.71%
Operating Margin
20.61%
↑ 20.61%
Gross Margin
98.25%
↑ 98.25%
Net Profit Margin
12.68%
↑ 12.68%
ROE
11.81%
↑ 11.81%
ROIC
15.71%
↑ 15.71%
Neurocrine Biosciences, Inc. (NBIX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Neurocrine Biosciences, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $627.70M | $622.10M | $590.20M | $515.30M |
| Cost of Revenue | $9.30M | $8.00M | $15.60M | $12.80M |
| Gross Profit | $618.40M | $614.10M | $574.60M | $502.50M |
| Gross Profit Ratio | $0.99 | $0.99 | $0.97 | $0.98 |
| R&D Expenses | $185.60M | $195.00M | $184.70M | $154.10M |
| SG&A Expenses | $287.80M | $234.30M | $242.00M | $243.10M |
| Operating Expenses | $476.40M | $430.30M | $426.70M | $397.20M |
| Total Costs & Expenses | $485.70M | $438.30M | $442.30M | $410.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $1.10M |
| Depreciation & Amortization | $7.10M | $6.50M | $7.30M | $6.20M |
| EBITDA | $169.70M | $191.30M | $155.20M | $111.50M |
| EBITDA Ratio | $0.27 | $0.31 | $0.26 | $0.22 |
| Operating Income | $142.00M | $183.80M | $147.90M | $105.30M |
| Operating Income Ratio | $0.23 | $0.30 | $0.25 | $0.20 |
| Other Income/Expenses (Net) | $20.60M | $6.50M | -$46.80M | -$64.80M |
| Income Before Tax | $162.60M | $190.30M | $98.60M | $34.50M |
| Income Before Tax Ratio | $0.26 | $0.31 | $0.17 | $0.07 |
| Income Tax Expense | $59.50M | $60.50M | $33.60M | -$8.90M |
| Net Income | $103.10M | $129.80M | $65.00M | $43.40M |
| Net Income Ratio | $0.16 | $0.21 | $0.11 | $0.08 |
| EPS | $1.03 | $1.28 | $0.64 | $0.43 |
| Diluted EPS | $1.00 | $1.24 | $0.63 | $0.42 |
| Weighted Avg Shares Outstanding | $100.00M | $101.10M | $100.80M | $99.80M |
| Weighted Avg Shares Outstanding (Diluted) | $102.90M | $104.30M | $103.90M | $103.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan